Hercules, CA — May 5, 2014 — Bio-Rad Laboratories, Inc. today announced the launch of its CytoTrack Cell Proliferation Assays that provide unmatched flexibility when designing a multicolor flow cytometry experiment, allowing researchers to efficiently stain and track live cells in four colors for up to 10 generations — two more generations than other currently available methods can follow.
CFDA-SE, the most commonly used reagent for monitoring cell proliferation, is difficult to use in multicolor experiments because it has the same spectra as green fluorescent protein and the most frequently used fluorophore, fluorescein.
Unlike CFDA-SE and other popular cell proliferation assays that are available in only one color, Bio-Rad’s CytoTrack Assays are available in four different emission wavelengths ranging from blue to far red. This allows researchers to choose the one most suitable for their multicolor flow cytometric experiment.
The CytoTrack Assay dye reacts with primary amines using a proprietary chemistry that provides effective labeling of cells without the large efflux usually seen with CFDA-SE.
“This unique feature allows researchers to easily visualize up to 10 cell divisions, making it ideal for those interested in studying the induction and inhibition of cell division in any in vitro experimental model,” said Mary Thao, Bio-Rad Product Manager in the Gene Expression Division.
CytoTrack Assays come in easy-to-use vials with material sufficient for 50 experiments. The dye can be added directly into the culture medium, allowing researchers to save time.
Bio-Rad offers additional reagents and consumables to complete each step of flow cytometry experiments, such as cell viability assays, primary antibodies, and antibody labeling kits.
For more information about Bio-Rad’s cell proliferation assays, please visit bio-rad.com/cellproliferation.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) designs, manufactures, and distributes a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs over 7,750 people worldwide and had revenues exceeding $2.1 billion in 2013. For more information, visit our website at www.bio-rad.com.
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company’s risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.
For more information contact:
Steve Kulisch
Bio-Rad Laboratories, Inc.
510-741-5638
Steve_Kulisch@bio-rad.com
Ken Li
Chempetitive Group
312-997-2436 x 112
kli@chempetitive.com
Help employers find you! Check out all the jobs and post your resume.
